डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

bristol laboratories ltd. - ibuprofen - filmovertrukne tabletter - 600 mg

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

orion corporation - ibuprofen - filmovertrukne tabletter - 200 mg

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

orion corporation - ibuprofen - filmovertrukne tabletter - 400 mg

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

mcneil denmark aps - ibuprofen - filmovertrukne tabletter - 200 mg

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

merck europe b.v. - avelumab - neuroendocrine tumorer - andre antineoplastiske midler, monoklonale antistoffer - bavencio er indiceret som monoterapi til behandling af voksne patienter med metastatisk merkel cellecarcinom (mcc). bavencio i kombination med axitinib er angivet for den første linje behandling af voksne patienter med fremskredent renalcellecarcinom (rcc). bavencio is indicated as monotherapy for the first‑line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc) who are progression-free following platinum‑based chemotherapy.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - carcinom, squamous cell - antineoplastiske midler - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - ibuprofen - filmovertrukne tabletter - 200 mg

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - ibuprofen - filmovertrukne tabletter - 400 mg

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - pemetrexeddinatrium 2,5-hydrat - infusionsvæske, opløsning - 10 mg/ml

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotika og kemoterapeutiske midler til dermatologisk brug - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.